Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons

Neuroscience Letters

Volumn 435, Issue 1, 2008, Pages 34-39

  Takahashi, Tsutomu ^a,b   Suzuki, Michio ^a,b   Tsunoda, Masahiko ^a   Kawamura, Yukiko ^d,e   Takahashi, Nagahide ^d,f   Tsuneki, Hiroshi ^a   Kawasaki, Yasuhiro ^a,b   Zhou, Shi Yu ^a,b,c   Kobayashi, Soushi ^a   Sasaoka, Toshiyasu ^a   Seto, Hikaru ^a   Kurachi, Masayoshi ^a,b   Ozaki, Norio ^d  

^a UNIVERSITY OF TOYAMA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c DALIAN MEDICAL UNIVERSITY   (China)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e MEIJO UNIVERSITY   (Japan)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Brain derived neurotrophic factor; Magnetic resonance imaging; Parahippocampal gyrus; Prefrontal cortex; Schizophrenia; Val66Met polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ALLELE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FRONTAL CORTEX; GENETIC ANALYSIS; HETEROZYGOTE DETECTION; HIPPOCAMPUS; HOMOZYGOSITY; HUMAN; JAPANESE; MALE; MENTAL PATIENT; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; VOLUMETRY;

ADULT; AMINO ACID SUBSTITUTION; ATROPHY; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DNA MUTATIONAL ANALYSIS; FEMALE; FUNCTIONAL LATERALITY; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; PARAHIPPOCAMPAL GYRUS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; VALINE;

EID: 41149098485     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.02.004     Document Type: Article

References (43)

1. Agartz I., Sedvall G.C., Terenius L., Kulle B., Frigessi A., Hall H., and Jonsson E.G. BDNF gene variants and brain morphology in schizophrenia. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 141 (2006) 513-523
2. Andreasen N.C. Scale for the Assessment of Negative Symptoms/Scale for the Assessment of Positive Symptoms [manual] (1984), University of Iowa Press, Iowa City
3. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., and Zubieta J.K. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol. Psychiatr. 59 (2006) 812-815
4. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., and Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
5. Friston K.J., Liddle P.F., Frith C.D., Hirsch S.R., and Frackowiak R.S. The left medial temporal region and schizophrenia: a PET study. Brain 115 (1992) 367-382
6. Goldman-Rakic P.S., and Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 23 (1997) 437-458
7. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatr. 160 (2003) 636-645
8. Guillin O., Demily C., and Thibaut F. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine. Int. Rev. Neurobiol. 78 (2007) 377-395
9. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., and Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23 (2003) 6690-6694
10. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., Sun Z., Sampson A.R., and Lewis D.A. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J. Neurosci. 25 (2005) 372-383
11. Ho B.C., Andreasen N.C., Dawson J.D., and Wassink T.H. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am. J. Psychiatry 164 (2007) 1890-1899
12. Ho B.C., Milev P., O'Leary D.S., Librant A., Andreasen N.C., and Wassink T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch. Gen. Psychiatr. 63 (2006) 731-740
13. Hong C.J., Yu Y.W., Lin C.H., and Tsai S.J. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett. 349 (2003) 206-208
14. Inoue H., Yamasue H., Tochigi M., Suga M., Minato T., Abe O., Yamada H., Aoki S., Kato N., Kasai K., and Sasaki T. Lack of association between brain-derived neurotorophic factor val66met polymorphism and volume of amygdala and hippocampus in a Japanese population. Ann. Rep. Pharmacopsychiatry Res. 38 (2006) 99-104 [in Japanese]
15. Jonsson E.G., Edman-Ahlbom B., Sillen A., Gunnar A., Kulle B., Frigessi A., Vares M., Ekholm B., Wode-Helgodt B., Schumacher J., Cichon S., Agartz I., Sedvall G.C., Hall H., and Terenius L. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 924-933
16. Krebs M.O., Guillin O., Bourdell M.C., Schwartz J.C., Olie J.P., Poirier M.F., and Sokoloff P. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol. Psychiatry 5 (2000) 558-562
17. Lu B. BDNF and activity-dependent synaptic modulation. Learn. Mem. 10 (2003) 86-98
18. Lu B., and Chow A. Neurotrophins and hippocampal synaptic transmission and plasticity. J. Neurosci. Res. 58 (1999) 76-87
19. Naoe Y., Shinkai T., Hori H., Fukunaka Y., Utsunomiya K., Sakata S., Matsumoto C., Shimizu K., Hwang R., Ohmori O., and Nakamura J. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis. Neurosci. Lett. 415 (2007) 108-112
20. Nemoto K., Ohnishi T., Mori T., Moriguchi Y., Hashimoto R., Asada T., and Kunugi H. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci. Lett. 397 (2006) 25-29
21. Niu L., Matsui M., Zhou S.-Y., Hagino H., Takahashi T., Yoneyama E., Kawasaki Y., Suzuki M., Seto H., Ono T., and Kurachi M. Volume reduction of the amygdala in patients with schizophrenia: a magnetic resonance imaging study. Psychiatry Res. 132 (2004) 41-51
22. Numata S., Ueno S., Iga I., Yamauchi K., Hongwei S., Ohta K., Kinouchi S., Shibuya-Tayoshi S., Tayoshi S., Aono M., Kameoka N., Sumitani S., Tomotake M., Kaneda Y., Taniguchi T., Ishimoto Y., and Ohmori T. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci. Lett. 401 (2006) 1-5
23. Pantelis C., Yücel M., Wood S.J., Velakoulis D., Sun D., Berger G., Stuart G.W., Yung A., Phillips L., and McGorry P.D. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull. 31 (2005) 672-696
24. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., Egan M.F., Meyer-Lindenberg A., and Weinberger D.R. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci. 24 (2004) 10099-10102
25. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2 (2001) 24-32
26. Roberts G.W. Schizophrenia: a neuropathological perspective. Br. J. Psychiatry 158 (1992) 8-17
27. Schrk H., and Falkai P. Effects of antipsychotics on brain structure. Curr. Opin. Psychiatry 19 (2006) 145-150
28. Seidman L.J., Pantelis C., Keshavan M.S., Faraone S.V., Goldstein J.M., Horton N.J., Makris N., Falkai P., Caviness V.S., and Tsuang M.T. A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr. Bull. 29 (2003) 803-830
29. Selemon L.D., Kleinman J.E., Herman M.M., and Goldman-Rakic P.S. Smaller frontal gray matter volume in postmortem schizophrenic brains. Am. J. Psychiatry 159 (2002) 1983-1991
30. Shenton M.E., Dickey C.C., Frumin M., and McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 49 (2001) 1-52
31. Shimizu E., Hashimoto K., and Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 126 (2004) 122-123
32. Suzuki M., Zhou S.-Y., Takahashi T., Hagino H., Kawasaki Y., Niu L., Matsui M., Seto H., and Kurachi M. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis. Brain 128 (2005) 2109-2122
33. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., Ashtari M., Napolitano B., Bilder R.M., Kane J.M., Goldman D., and Malhotra A.K. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol. Psychiatry 10 (2005) 631-636
34. Takahashi T., Kawasaki Y., Kurokawa K., Hagino H., Nohara S., Yamashita I., Nakamura K., Murata M., Matsui M., Suzuki M., Seto H., and Kurachi M. Lack of normal structural asymmetry of the anterior cingulate gyrus in female patients with schizophrenia: a volumetric magnetic resonance imaging study. Schizophr. Res. 55 (2002) 69-81
35. Takahashi T., Suzuki M., Zhou S.-Y., Tanino R., Hagino H., Kawasaki Y., Matsui M., Seto H., and Kurachi M. Morphologic alterations of the parcellated superior temporal gyrus in schizophrenia spectrum. Schizophr. Res. 83 (2006) 131-143
36. Tochigi M., Otowa T., Suga M., Rogers M., Minato T., Yamasue H., Kasai K., Kato N., and Sasaki T. No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits. Schizophr. Res. 87 (2006) 45-47
37. Tsai S.J., Hong C.J., Yu Y.W., and Chen T.J. Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology 49 (2004) 13-16
38. Wang Z.R., Zhou D.F., Cao L.Y., Tan Y.L., Zhang X.Y., Li J., Lu L., Wu G.Y., Kosten T.A., and Kosten T.R. Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia. Schizophr. Res. 97 (2007) 299-301
39. Webster M.J., Weickert C.S., Herman M.M., and Kleinman J.E. BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Res. Dev. Brain Res. 139 (2002) 139-150
40. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., and Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 8 (2003) 592-610
41. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research (1993), World Health Organization, Geneva
42. Zhou S.-Y., Suzuki M., Hagino H., Takahashi T., Kawasaki Y., Nohara S., Yamashita I., Seto H., and Kurachi M. Decreased volume and increased asymmetry of the anterior limb of the internal capsule in patients with schizophrenia. Biol. Psychiatry 54 (2003) 427-436
43. Zilles K., Kawashima R., Dabringhaus A., Fukuda H., and Schormann T. Hemispheric shape of European and Japanese brains: 3-D MRI analysis of intersubject variability, ethnical, and gender differences. Neuroimage 13 (2001) 262-271